Wednesday's ETF Movers: PTF, IHF
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 26 2025
0mins
Source: NASDAQ.COM
Performance of iShares U.S. Healthcare Providers ETF: The iShares U.S. Healthcare Providers ETF is underperforming, down approximately 1.5% in Wednesday afternoon trading.
Decline of Specific Stocks: Notable declines among its components include Community Health Systems, which fell by about 8.6%, and Molina Healthcare, which decreased by around 7.3%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MOH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MOH
Wall Street analysts forecast MOH stock price to fall
14 Analyst Rating
3 Buy
9 Hold
2 Sell
Hold
Current: 195.530
Low
155.00
Averages
180.85
High
250.00
Current: 195.530
Low
155.00
Averages
180.85
High
250.00
About MOH
Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Health Insurers Show Strong Q1 Performance Amid Cost Challenges
- Strong Q1 Results: Major health insurers like UnitedHealth, Elevance, Cigna, and Humana exceeded expectations, boosting investor sentiment despite rising medical costs, reflecting effective strategies in pricing and cost control.
- Increased Medical Reserves: Analysts noted that insurers have strengthened medical reserves, providing a cushion for future claims, a strategy that could imply positive earnings implications for 2026, although the real data from Q2 remains crucial.
- Market Adjustment Strategies: Companies have successfully reduced medical loss ratios by exiting unprofitable markets and adjusting pricing and benefits of medical plans, demonstrating effective responses to increased demand for medical services post-pandemic, thereby enhancing market competitiveness.
- Critical Future Outlook: The second quarter will serve as a true test for insurers, as more claims data becomes available, investors will closely monitor medical loss ratios and changes in full-year outlooks to assess whether companies can sustain current growth momentum.
See More
LKQ Corporation Faces Shareholder Investigation Over Alleged Misconduct
- Shareholder Investigation Initiated: Grabar Law Office is investigating whether LKQ Corporation's executives breached their fiduciary duties, affecting shareholders who purchased shares before February 27, 2023, potentially leading to legal liabilities and financial losses for the company.
- Inadequate Disclosure of Acquisition Risks: LKQ allegedly failed to disclose that FinishMaster was losing major customers prior to the acquisition, severely undermining investor confidence in the company's financial health and potentially impacting future financing capabilities.
- Significant Financial Guidance Cuts: LKQ has cut its financial guidance multiple times between April 2024 and July 2025 due to missed revenue and margin targets, highlighting the company's vulnerability in a competitive market, which may lead to further declines in stock price.
- Potential Legal Consequences Increase: As the investigation progresses, LKQ may face class action lawsuits from shareholders seeking corporate reforms and fund recovery, which could have long-term repercussions on the company's reputation and market trust.
See More
LKQ Corporation Under Investigation for Investor Claims
- Investor Investigation Launched: Grabar Law Office is investigating LKQ Corporation for potential breaches of fiduciary duties by its executives, allowing investors who purchased shares before February 27, 2023, to seek corporate reforms and fund recovery.
- Acquisition Risk Disclosure Failure: Allegations against LKQ regarding its $2.1 billion acquisition of Uni-Select claim that executives failed to disclose that FinishMaster was losing major customers prior to the acquisition, severely undermining investor confidence in the company's financial health.
- Significant Financial Guidance Cuts: Between April 2024 and July 2025, LKQ cut its financial guidance multiple times, admitting that FinishMaster had been losing customers before the acquisition, indicating ongoing market share losses due to competitive pressures and revealing the company's vulnerable market position.
- Potential Legal Consequences: Investors can participate in a class action lawsuit for compensation; if LKQ fails to adequately address these allegations, it may face greater legal and financial risks, impacting its future market performance and investor confidence.
See More
LKQ Corporation Faces Shareholder Investigation Over Alleged Misconduct
- Shareholder Investigation Launched: Grabar Law Office is investigating LKQ Corporation for potential breaches of fiduciary duties by its executives, allowing investors who purchased shares before February 27, 2023, to seek corporate reforms and fund recovery.
- Inadequate Risk Disclosure: LKQ allegedly misled investors regarding its $2.1 billion acquisition of Uni-Select, failing to disclose that FinishMaster was losing major customers, which distorted perceptions of the company's financial health and eroded market confidence.
- Significant Financial Guidance Cuts: Between April 2024 and July 2025, LKQ repeatedly lowered its financial guidance, admitting that FinishMaster had been losing customers prior to the acquisition, highlighting the competitive pressures the company faces.
- Potential Legal Consequences: Due to the failure to disclose critical information in a timely manner, LKQ may face class action lawsuits, with investors encouraged to participate through Grabar Law Office to seek legal remedies and compensation.
See More
Bank of America Upgrades Molina Healthcare to Buy with $250 Price Target
- Rating Upgrade: Bank of America upgraded Molina Healthcare (MOH) from Underperform to Buy and raised its price target from $152 to $250, reflecting confidence in the favorable margin outlook for the company's Medicaid business.
- Profit Outlook Improvement: Analyst Kevin Fischbeck noted that Molina's Medicaid margins are expected to bottom out in 2026, with states gradually adjusting trend and risk pools in 2024/25, indicating a path for margin recovery and future profitability.
- Earnings Per Share Forecast: Assuming the company's long-term targets and normalized margins by 2029, Fischbeck anticipates Molina's earnings per share to improve by over $30 in the next three years, significantly boosting stock potential and attractiveness for investors.
- Market Uncertainty: Despite the large disparities in Medicaid rates and trends, along with uncertainties in other business areas, Fischbeck believes that Molina could conservatively set a 2029 EPS target of $30, nearly double the consensus estimate of $17.32, highlighting its long-term investment value.
See More
Latest Wall Street Rating Updates
- Starbucks Rating Maintained: Morgan Stanley reiterates its overweight rating on Starbucks, indicating that the ongoing debate about the company's earnings power reflects an improving narrative that may attract more investor interest.
- Robinhood Outlook Positive: Bernstein maintains an outperform rating on Robinhood, noting that HOOD stock marked a bottom in Q1 and has started strong in April, suggesting increasing market confidence in its future.
- CoreWeave Price Target Raised: Wells Fargo raises CoreWeave's price target from $125 to $135, believing that the company's leading position in AI infrastructure will allow it to benefit as demand continues to outpace supply.
- Telecom Argentina Upgrade: JPMorgan upgrades Telecom Argentina from neutral to overweight, expecting substantial benefits from market consolidation as the antitrust review of its acquisition of Telefonica Argentina nears completion.
See More
Health Insurers Show Strong Q1 Performance Amid Cost Challenges
- Strong Q1 Results: Major health insurers like UnitedHealth, Elevance, Cigna, and Humana exceeded expectations, boosting investor sentiment despite rising medical costs, reflecting effective strategies in pricing and cost control.
- Increased Medical Reserves: Analysts noted that insurers have strengthened medical reserves, providing a cushion for future claims, a strategy that could imply positive earnings implications for 2026, although the real data from Q2 remains crucial.
- Market Adjustment Strategies: Companies have successfully reduced medical loss ratios by exiting unprofitable markets and adjusting pricing and benefits of medical plans, demonstrating effective responses to increased demand for medical services post-pandemic, thereby enhancing market competitiveness.
- Critical Future Outlook: The second quarter will serve as a true test for insurers, as more claims data becomes available, investors will closely monitor medical loss ratios and changes in full-year outlooks to assess whether companies can sustain current growth momentum.
See More
LKQ Corporation Faces Shareholder Investigation Over Alleged Misconduct
- Shareholder Investigation Initiated: Grabar Law Office is investigating whether LKQ Corporation's executives breached their fiduciary duties, affecting shareholders who purchased shares before February 27, 2023, potentially leading to legal liabilities and financial losses for the company.
- Inadequate Disclosure of Acquisition Risks: LKQ allegedly failed to disclose that FinishMaster was losing major customers prior to the acquisition, severely undermining investor confidence in the company's financial health and potentially impacting future financing capabilities.
- Significant Financial Guidance Cuts: LKQ has cut its financial guidance multiple times between April 2024 and July 2025 due to missed revenue and margin targets, highlighting the company's vulnerability in a competitive market, which may lead to further declines in stock price.
- Potential Legal Consequences Increase: As the investigation progresses, LKQ may face class action lawsuits from shareholders seeking corporate reforms and fund recovery, which could have long-term repercussions on the company's reputation and market trust.
See More
LKQ Corporation Under Investigation for Investor Claims
- Investor Investigation Launched: Grabar Law Office is investigating LKQ Corporation for potential breaches of fiduciary duties by its executives, allowing investors who purchased shares before February 27, 2023, to seek corporate reforms and fund recovery.
- Acquisition Risk Disclosure Failure: Allegations against LKQ regarding its $2.1 billion acquisition of Uni-Select claim that executives failed to disclose that FinishMaster was losing major customers prior to the acquisition, severely undermining investor confidence in the company's financial health.
- Significant Financial Guidance Cuts: Between April 2024 and July 2025, LKQ cut its financial guidance multiple times, admitting that FinishMaster had been losing customers before the acquisition, indicating ongoing market share losses due to competitive pressures and revealing the company's vulnerable market position.
- Potential Legal Consequences: Investors can participate in a class action lawsuit for compensation; if LKQ fails to adequately address these allegations, it may face greater legal and financial risks, impacting its future market performance and investor confidence.
See More
LKQ Corporation Faces Shareholder Investigation Over Alleged Misconduct
- Shareholder Investigation Launched: Grabar Law Office is investigating LKQ Corporation for potential breaches of fiduciary duties by its executives, allowing investors who purchased shares before February 27, 2023, to seek corporate reforms and fund recovery.
- Inadequate Risk Disclosure: LKQ allegedly misled investors regarding its $2.1 billion acquisition of Uni-Select, failing to disclose that FinishMaster was losing major customers, which distorted perceptions of the company's financial health and eroded market confidence.
- Significant Financial Guidance Cuts: Between April 2024 and July 2025, LKQ repeatedly lowered its financial guidance, admitting that FinishMaster had been losing customers prior to the acquisition, highlighting the competitive pressures the company faces.
- Potential Legal Consequences: Due to the failure to disclose critical information in a timely manner, LKQ may face class action lawsuits, with investors encouraged to participate through Grabar Law Office to seek legal remedies and compensation.
See More
Bank of America Upgrades Molina Healthcare to Buy with $250 Price Target
- Rating Upgrade: Bank of America upgraded Molina Healthcare (MOH) from Underperform to Buy and raised its price target from $152 to $250, reflecting confidence in the favorable margin outlook for the company's Medicaid business.
- Profit Outlook Improvement: Analyst Kevin Fischbeck noted that Molina's Medicaid margins are expected to bottom out in 2026, with states gradually adjusting trend and risk pools in 2024/25, indicating a path for margin recovery and future profitability.
- Earnings Per Share Forecast: Assuming the company's long-term targets and normalized margins by 2029, Fischbeck anticipates Molina's earnings per share to improve by over $30 in the next three years, significantly boosting stock potential and attractiveness for investors.
- Market Uncertainty: Despite the large disparities in Medicaid rates and trends, along with uncertainties in other business areas, Fischbeck believes that Molina could conservatively set a 2029 EPS target of $30, nearly double the consensus estimate of $17.32, highlighting its long-term investment value.
See More
Latest Wall Street Rating Updates
- Starbucks Rating Maintained: Morgan Stanley reiterates its overweight rating on Starbucks, indicating that the ongoing debate about the company's earnings power reflects an improving narrative that may attract more investor interest.
- Robinhood Outlook Positive: Bernstein maintains an outperform rating on Robinhood, noting that HOOD stock marked a bottom in Q1 and has started strong in April, suggesting increasing market confidence in its future.
- CoreWeave Price Target Raised: Wells Fargo raises CoreWeave's price target from $125 to $135, believing that the company's leading position in AI infrastructure will allow it to benefit as demand continues to outpace supply.
- Telecom Argentina Upgrade: JPMorgan upgrades Telecom Argentina from neutral to overweight, expecting substantial benefits from market consolidation as the antitrust review of its acquisition of Telefonica Argentina nears completion.
See More
